尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the complete record of transactions filed by Afable Richard, 董事. Insider active across 1 company, notably Acelrx Pharmaceuticals INC. Aggregated, 3 filings have been logged. History available since 17 June 2021. The latest transaction was filed on 10 October 2023 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Richard Afable is a Director of ACELRX PHARMACEUTICALS INC. In this role, he participates in the governance and strategy of the company, which specializes in drug development. Richard brings valuable expertise in corporate strategy and product development, contributing to the direction of key decisions for AcelRx.